Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins
- PMID: 6788066
Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins
Abstract
Incubation of factor IX with non-precipitating alloantibodies to factor IX gives rise to soluble complexes between factor IX and the alloantibodies. These complexes appear as a factor IX molecule with a reduced mobility in crossed immunoelectrophoresis against a rabbit antiserum to factor IX. This factor IX immunoprecipitate was used for the study of alloantibodies to factor IX from five patients with severe haemophilia B (antibody titres 0.1--800 units/ml plasma). Incorporation of antiserum to k light chains or lambda light chains of human immunoglobulin G in an intermediate gel in crossed immunoelectrophoresis gave a reduction of the factor IX precipitin arc, indicating the presence of immunoglobulin G alloantibodies containing both k and lambda light chains in complex with factor IX. Incubation of the factor IX immunoprecipitate with peroxidase-conjugated antisera to the same immunoglobulins, and staining for peroxidase activity, confirmed the presence of immunoglobulin G containing both types of light chains in the factor immunoprecipitate. It is concluded that all five alloantibodies were polyclonal immunoglobulin G antibodies. The technique had the advantage that the light chain types of low-titre antibodies could be determined, and it may be suitable for further characterization of alloantibodies to factor IX if antibodies to immunoglobulin subclasses are available.
Similar articles
-
Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.Thromb Haemost. 1981 Dec 23;46(4):684-6. Thromb Haemost. 1981. PMID: 7330818
-
Analysis of IgG heavy chain subclasses of alloantibodies to factor IX by crossed immunoelectrophoresis of factor IX using the intermediate gel technique.Br J Haematol. 1983 Apr;53(4):687-8. doi: 10.1111/j.1365-2141.1983.tb07323.x. Br J Haematol. 1983. PMID: 6403026 No abstract available.
-
Inhibitors to factor IX contain all IgG subclasses except IgG3.Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(4):545-8. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990. PMID: 1714858
-
[Factor IX and factor IX inhibitor].Nihon Rinsho. 2004 Dec;62 Suppl 12:647-50. Nihon Rinsho. 2004. PMID: 15658413 Review. Japanese. No abstract available.
-
Inhibitors in young boys with haemophilia.Baillieres Best Pract Res Clin Haematol. 2000 Sep;13(3):457-68. doi: 10.1053/beha.2000.0088. Baillieres Best Pract Res Clin Haematol. 2000. PMID: 11030045 Review.
Cited by
-
Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.Infect Immun. 1986 Feb;51(2):571-8. doi: 10.1128/iai.51.2.571-578.1986. Infect Immun. 1986. PMID: 3002987 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources